Pancreatic Feedback Loop: Insulin and Glucagon in Glucose Homeostasis

Negative Feedback System

The pancreatic islets (islets of Langerhans) maintain blood glucose ~70–100 mg/dL (fasting) via opposing hormones:

High Glucose → Insulin Release (Beta Cells)

1. Glucose enters beta cell via GLUT2 → glycolysis → ↑ ATP/ADP.
2. K_ATP channels close → depolarization → voltage-gated Ca²⁺ channels open.
3. Ca²⁺ influx → insulin granule exocytosis.
4. Insulin binds receptor (RTK) → GLUT4 translocation (muscle, fat) → glucose uptake.
5. Insulin promotes glycogen synthesis (liver/muscle), lipogenesis, protein synthesis.
6. Glucose falls → feedback inhibits insulin secretion.

Low Glucose → Glucagon Release (Alpha Cells)

1. Low glucose → reduced ATP → K_ATP channels open → hyperpolarization (but alpha cells have different ion channel regulation).
2. Paracrine: Low insulin + low Zn²⁺ + low GABA disinhibit alpha cells.
3. Glucagon → GPCR on hepatocytes → cAMP → PKA → phosphorylase kinase → glycogen phosphorylase → glycogenolysis.
4. Also stimulates gluconeogenesis (amino acids, glycerol).
5. Inhibits glycolysis (PFK-2/FBPase-2 switch).
6. Glucose rises → feedback inhibits glucagon (via insulin, glucose, GLP-1).

Additional Regulators

• Incretins (GLP-1, GIP): Enhance glucose-dependent insulin secretion; suppress glucagon.
• Somatostatin (Delta cells): Inhibits both insulin and glucagon.
• Amylin (co-secreted with insulin): Slows gastric emptying, suppresses glucagon, promotes satiety.
• Neural input: Vagus (parasympathetic) stimulates insulin; sympathetic (stress) stimulates glucagon, inhibits insulin.

Clinical Relevance

• Type 1 DM: Autoimmune beta cell destruction → absolute insulin deficiency.
• Type 2 DM: Insulin resistance + progressive beta cell failure + relative glucagon excess.
• Therapies target this loop: insulin, GLP-1 RAs, SGLT2i, DPP-4i, glucagon receptor antagonists.